Superpower peptides available for pre-order. Get first access.

Peptide science

Are peptides legal?

Peptide legality in the US depends on the route: FDA-approved drug, compounded by a licensed pharmacy, or research-only. Status as of November 2026.

Quick answer

Peptide legality in the US depends on the route, not the molecule. New FDA-approved peptide drugs typically complete Phase 1 to 3 trials, with Phase 3 enrolling 300 to 3,000 volunteers. Compounded peptides are not FDA-approved, and FDA does not verify their safety or quality. On October 30, 2026, HHS issued a non-binding draft policy covering six peptides at 503A pharmacies. Research-use-only peptides have no approval for human use.

Published
November 9, 2026
Last updated
November 9, 2026

Peptide legality depends on the regulatory route

Whether peptides are legal in the US depends on their regulatory route. Federal law treats FDA-approved peptide drugs, pharmacy-compounded peptides, and research-use-only peptides differently. No peptide class is legal or illegal as a whole, since one molecule can take several routes. This guide reflects federal policy as of November 2026.

RouteWho makes itFDA review before saleHuman use
FDA-approved peptide drugA drug manufacturerYes, after Phase 1 to Phase 3 human trials1By prescription, with labeled indications, dosage, and warnings2
Compounded by a 503A pharmacyA state-licensed pharmacyNo; FDA does not verify safety, effectiveness, or quality3For an identified patient with a valid prescription4
Compounded by a 503B outsourcing facilityAn outsourcing facility held to manufacturing standards and FDA inspection5NoPatients, or clinics as office stock without a patient-specific prescription
Dietary supplementA supplement makerNo drug approval; deemed to be a food6Must be intended for ingestion6
CosmeticA cosmetic makerNo premarket approval, except for color additives7Cleansing or appearance claims7
Research use onlyOften foreign manufacturers8NoNot approved; little or no human safety information9

FDA-approved peptide drugs carry the most human testing of the six routes.

FDA-approved peptide drugs are reviewed before reaching patients

An FDA-approved peptide drug is legal to prescribe because it passed a review of its safety and efficacy10. Phase 3, the largest pre-approval stage, typically enrolls 300 to 3,000 volunteers1 over one to four years.

Approved peptide drugs, including GLP-1 receptor agonists, help manage diabetes, obesity, cancer, and rare diseases11.

Compounded and research copies inherit none of that trial evidence, since they skip FDA's review for safety and effectiveness12.

Peptide supplements and cosmetics follow different rules than drugs

Peptide supplements and cosmetics need no prescription, but a seller's claims7 can turn either one into a drug.

A dietary supplement must be intended for ingestion6, as oral collagen peptides are, so injectable peptides cannot qualify. Substances first approved or studied as new drugs6 are excluded too.

Cosmetics need no FDA approval before sale7, apart from color additives. A peptide skincare cream marketed to change how the body works is regulated as a drug.

Peptides labeled for research use only fit none of these routes.

Research-use-only peptides are not approved for human use

Research-use-only peptides have no FDA approval for any human use. Federal officials have called those from foreign manufacturers a safety risk to US patients8.

"For Research Use Only" is a federal labeling statement for diagnostic products still in laboratory research20.

Rigorous human safety data are scarce10 for unapproved peptides. In one review of BPC-157 in sports medicine, 35 of 36 studies were preclinical21, with no clinical safety data.

FDA's concerns include immune reactions9, peptide-related impurities, and poorly characterized active ingredients. Case reports also link melanotan II to serious harms, including melanoma9.

Poorly controlled synthesis can leave peptides with missing amino acids, oxidation, or unrelated peptides22. Falsified cysteine-containing peptide drugs from suspected illegal online pharmacies tested 5% to 75% pure23. Some samples held arsenic up to 10 times23 the injectable safety limit.

A research label verifies neither a product's contents nor any human testing, so the label says little about long-term safety.

Long-term safety data on peptides remain limited

One large outcome trial of approved semaglutide followed 17,604 adults for 39.8 months on average24, about 3.3 years. For unapproved peptides, rigorous human safety data remain scarce10.

Reports on compounded GLP-1 drugs cite preparation errors and contamination more often25 than reports on approved versions. FDA reviewers found insufficient clinical safety information26 on BPC-157 and no studies of its cancer risk.

Human testing behind a peptide tracks the same regulatory route that decides its legal status.

Where can I learn about peptides?

Peptide rules in the US shifted several times in 2026, from withdrawn nominations to a draft HHS policy. For anyone following those changes, Superpower’s peptide library is a dependable reference. Each guide is written and fact-checked by a team of health journalists and licensed clinicians.

One molecule can take several legal routes with an identical structure, and the science behind peptides explains what that structure is and how it acts.

IMPORTANT SAFETY INFORMATION

This article describes how US federal law treats peptides by regulatory route as of November 2026. It is general information, not legal or medical advice, and peptide status can change as HHS and FDA finalize pending policies.

FDA-approved peptide drugs are prescription medications whose FDA-approved labeling lists their indications, dosing, warnings, and side effects. Compounded medications are prepared by a licensed compounding pharmacy and are not FDA-approved. They have not been evaluated by the FDA for safety, efficacy, or quality in the same manner as commercially manufactured branded products. Compounded semaglutide and compounded tirzepatide may differ from the branded versions in formulation, concentration, and inactive ingredients.

Peptides labeled "for research use only" or "not for human consumption" are not approved for human use, and FDA has not reviewed them for human safety, effectiveness, or quality. Products bought through unregulated channels may contain incorrect doses, contaminants, or misidentified compounds. Superpower Health does not prescribe, sell, or facilitate access to peptide products labeled "for research use only" or "not for human consumption."

This content is not a substitute for medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any peptide or prescription medication.

Prescribing information for FDA-approved drugs is available on DailyMed27. FDA's rules for compounding ingredients are on its page on bulk drug substances used in compounding13.

More peptide science